C-Path’s Translational Therapeutics Accelerator Announces $200,000 Grant for Drug Development Project in Inflammatory Bowel Disease

Critical Path Institute’s^® (C-Path) Translational Therapeutics Accelerator announced a $200,000 grant to Dr. Carlos Subauste to advance a promising new therapy for IBD.